financetom
Business
financetom
/
Business
/
Discovery+ prices go up by a dollar in first hike by streaming service this year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Discovery+ prices go up by a dollar in first hike by streaming service this year
Jan 7, 2025 10:23 AM

(Reuters) - Warner Bros Discovery's ( WBD ) streaming platform Discovery+ is increasing its monthly subscription price by $1, the company said on Tuesday, becoming the first streaming service to raise rates in the new year.

Last year, several streaming services, including Warner Bros Discovery's ( WBD ) flagship service Max, Paramount+, and Peacock, increased subscription prices to focus on profitability as the market matures and subscriber growth slows.

Discovery+'s ad-supported plan will now cost $5.99 per month, up from $4.99, while the ad-free plan will increase to $9.99 from $8.99.

New subscribers will see the price change immediately, with existing subscribers affected during their next billing cycle or from February 7.

Warner Bros Discovery ( WBD ) does not break out the number of subscribers for Discovery+, but it's believed to have a smaller user base than Max.

The service offers content from channels such as Food Network, Animal Planet, and Magnolia Network, with most of its programming also available on Max.

It streams adventure reality shows such as the "Deadliest Catch" and "Dual Survival".

Warner Bros Discovery ( WBD ) is undergoing a restructuring and announced in December its plans to separate its declining cable TV businesses, such as CNN, from streaming and studio operations like Max, setting the stage for a potential sale or spinoff of its TV business as more cable subscribers cut the cord.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mizuho Financial H1 Net Income Increases, Raises Fiscal 2025 EPS Outlook
Mizuho Financial H1 Net Income Increases, Raises Fiscal 2025 EPS Outlook
Nov 14, 2025
04:05 AM EST, 11/14/2025 (MT Newswires) -- Mizuho Financial ( MFG ) reported H1 net income Friday of 276.2 Japanese yen ($1.79) per diluted share, up from 223.35 yen a year earlier. Ordinary income for the six months ended Sept. 30 was 4.338 trillion yen, down from 4.585 trillion yen a year earlier. For fiscal year 2025 ending March 31,...
Mineralys Therapeutics Insider Sold Shares Worth $5,363,716, According to a Recent SEC Filing
Mineralys Therapeutics Insider Sold Shares Worth $5,363,716, According to a Recent SEC Filing
Nov 14, 2025
03:47 AM EST, 11/14/2025 (MT Newswires) -- Adam Scott Levy, Chief Financial Officer and Secretary, on November 11, 2025, sold 119,524 shares in Mineralys Therapeutics ( MLYS ) for $5,363,716. Following the Form 4 filing with the SEC, Levy has control over a total of 19,396 common shares of the company, with 19,396 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1933414/000193341425000152/xslF345X05/wk-form4_1763078493.xml ...
Sumitomo Mitsui Financial Fiscal H1 Earnings Rise, Ordinary Income Falls; Fiscal 2026 EPS Outlook Raised
Sumitomo Mitsui Financial Fiscal H1 Earnings Rise, Ordinary Income Falls; Fiscal 2026 EPS Outlook Raised
Nov 14, 2025
04:04 AM EST, 11/14/2025 (MT Newswires) -- Sumitomo Mitsui Financial Group ( SMFG ) reported fiscal H1 earnings Friday of 241.98 Japanese yen ($1.57) per diluted share, up from 184.72 yen a year earlier. Ordinary income for the half ended Sept. 30 was 5.206 trillion yen, down from 5.277 trillion yen a year earlier. The company said it now expects...
Mineralys Therapeutics Insider Sold Shares Worth $9,088,499, According to a Recent SEC Filing
Mineralys Therapeutics Insider Sold Shares Worth $9,088,499, According to a Recent SEC Filing
Nov 14, 2025
03:45 AM EST, 11/14/2025 (MT Newswires) -- Jon Congleton, Director, Chief Executive Officer, on November 11, 2025, sold 200,000 shares in Mineralys Therapeutics ( MLYS ) for $9,088,499. Following the Form 4 filing with the SEC, Congleton has control over a total of 631,305 common shares of the company, with 631,305 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1933414/000193341425000151/xslF345X05/wk-form4_1763078487.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved